Angiotensin II Type 2 Receptor Blockers
"Angiotensin II Type 2 Receptor Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR.
| Descriptor ID |
D057912
|
| MeSH Number(s) |
D27.505.519.162.750
|
| Concept/Terms |
Angiotensin II Type 2 Receptor Blockers- Angiotensin II Type 2 Receptor Blockers
- Type 2 Angiotensin Receptor Blockers
- Type 2 Angiotensin Receptor Antagonists
- Angiotensin 2 Receptor Antagonists
- Angiotensin II Type 2 Receptor Antagonists
|
Below are MeSH descriptors whose meaning is more general than "Angiotensin II Type 2 Receptor Blockers".
Below are MeSH descriptors whose meaning is more specific than "Angiotensin II Type 2 Receptor Blockers".
This graph shows the total number of publications written about "Angiotensin II Type 2 Receptor Blockers" by people in this website by year, and whether "Angiotensin II Type 2 Receptor Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Angiotensin II Type 2 Receptor Blockers" by people in Profiles.
-
Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system. Am Heart J. 2021 10; 240:46-57.
-
Clinical Characterization of Patients With COVID-19 in Primary Care in Catalonia: Retrospective Observational Study. JMIR Public Health Surveill. 2021 02 08; 7(2):e25452.
-
Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study. Microb Pathog. 2021 Mar; 152:104762.
-
Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia. PLoS One. 2020; 15(12):e0244349.
-
[Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study]. Ann Cardiol Angeiol (Paris). 2020 Nov; 69(5):247-254.
-
Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19. Hypertension. 2020 10; 76(4):e29-e30.
-
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging". Inflamm Res. 2020 Sep; 69(9):825-839.
-
Renin-angiotensin-aldosterone system inhibitors and COVID-19. CMAJ. 2020 05 19; 192(20):E553-E554.
-
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection. mBio. 2020 03 20; 11(2).
-
Reasons for Guideline Nonadherence at Heart Failure Discharge. J Am Heart Assoc. 2018 08 07; 7(15):e008789.